TY - JOUR
T1 - Taxonomy development for term standardization in activity resulting from medication review processes: A Delphi study
AU - Alharthi, Mohammed S.
AU - Scott, Sion
AU - Hughes, Carmel
AU - Bond, Christine
AU - Hatah, Ernieda
AU - Bryant, Linda
AU - Holland, Richard
AU - Kosari, Sam
AU - Baqir, Wasim
AU - Loke, Yoon
AU - Wright, David
N1 - Funding Information: The researcher (M.S.A.) would like to acknowledge the Deanship of Scientific Research at Taif University for its support during this study.
PY - 2024/4
Y1 - 2024/4
N2 - Background: Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact. Aim: To develop an international taxonomy of standardized terms and activity definitions related to medication reviews. Method: This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions. Results: Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education. Conclusion: Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.
AB - Background: Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact. Aim: To develop an international taxonomy of standardized terms and activity definitions related to medication reviews. Method: This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions. Results: Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education. Conclusion: Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.
KW - consensus
KW - medication review
KW - process evaluation
KW - standardization
KW - taxonomy
UR - http://www.scopus.com/inward/record.url?scp=85187140435&partnerID=8YFLogxK
U2 - 10.1093/ijpp/riae002
DO - 10.1093/ijpp/riae002
M3 - Article
C2 - 38387608
AN - SCOPUS:85187140435
VL - 32
SP - 180
EP - 185
JO - International Journal of Pharmacy Practice
JF - International Journal of Pharmacy Practice
SN - 0961-7671
IS - 2
ER -